Futuristic healthcare technology with CPET and FeNO testing for non-invasive clinical outcomes
Futuristic healthcare technology with CPET and FeNO testing for non-invasive clinical outcomes
Futuristic healthcare technology with CPET and FeNO testing for non-invasive clinical outcomes

Enhancing Clinical Outcomes with CPET and FeNO: A New Era in Non-Invasive Testing

Enhancing Clinical Outcomes with CPET and FeNO: A New Era in Non-Invasive Testing

Feb 5, 2025

Feb 5, 2025

Share:

The All India Institute of Medical Sciences (AIIMS) Raipur continues to set benchmarks in healthcare innovation and research, with the introduction of Cardiopulmonary Exercise Testing (CPET) and Exhaled Nitric Oxide (FeNO) estimation in its outpatient department (OPD). This strategic move underscores AIIMS Raipur’s commitment to enhancing diagnostic accuracy and improving patient care, particularly in the fields of pulmonary and cardiac health.

Revolutionizing Pulmonary and Cardiac Diagnostics

The integration of CPET and FeNO represents a significant advancement in non-invasive diagnostic capabilities.

CPET: A Game-Changer in Cardiopulmonary Assessment

Cardiopulmonary Exercise Testing (CPET) is a highly specialized, non-invasive diagnostic tool that evaluates the combined function of the heart, lungs, and muscles during exercise. This test is particularly crucial for:

  • Assessing unexplained exertional breathlessness

  • Determining exercise capacity in patients with chronic conditions

  • Guiding treatment for various pulmonary and cardiac disorders

Prof. Dr Sajal De, Head of the Department of Pulmonary Medicine, emphasized CPET’s role in optimizing patient management, enabling physicians to provide personalized treatment plans and monitor disease progression effectively.

FeNO: Enhancing Asthma Diagnosis and Management

The FeNO test, which measures nitric oxide levels in exhaled breath, plays a pivotal role in asthma diagnosis and treatment. As a non-invasive and highly precise diagnostic tool, FeNO aids in:

  • Assessing airway inflammation

  • Optimizing asthma medication and treatment adherence

  • Guiding dosage adjustments for better disease control

By integrating FeNO testing into the OPD, AIIMS Raipur is empowering clinicians with data-driven insights to make informed decisions and improve patient outcomes.

Leadership and Collaborative Efforts in Healthcare Advancement

Lt Gen Ashok Jindal (Retd), Executive Director & CEO, AIIMS Raipur, praised the Department of Pulmonary, Critical, and Sleep Medicine for spearheading these advancements. The acquisition and implementation of CPET and FeNO testing were made possible through the dedicated efforts of Prof. Dr Sajal De, along with Dr Ajay Behera and Dr Dibakar Sahu, both Additional Professors in the department.

Their collective vision and expertise have positioned AIIMS Raipur as a leader in advanced diagnostic solutions, further cementing its reputation as a pioneer in respiratory and cardiac healthcare.

A New Era of Precision Medicine at AIIMS Raipur

The introduction of CPET and FeNO at AIIMS Raipur marks a transformative shift in patient care. These state-of-the-art diagnostic tools are not only refining early detection and treatment strategies but also contributing to cutting-edge research in pulmonary and cardiac medicine. By leveraging technology-driven healthcare solutions, AIIMS Raipur continues to enhance patient outcomes, reduce disease burden, and optimize clinical decision-making.

Cardiopulmonary exercise test (CPET) performed on a patient with real-time data monitoring

This strategic healthcare integration reaffirms AIIMS Raipur’s dedication to delivering world-class medical services, ensuring that patients receive accurate diagnoses, personalized treatments, and improved quality of life.

With ongoing innovations and research-driven advancements, AIIMS Raipur is set to revolutionize diagnostic methodologies, paving the way for superior patient care in India’s evolving healthcare landscape.

Share: